Metilcrotonilglicinuria clinical trials

Explore recruiting metilcrotonilglicinuria clinical trials.

Also recruiting in Europe

Metilcrotonilglicinuria trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Development and delivery of personalized 3D-printed drugs to improve treatment adherence in children with rare diseases.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metilcrotonilglicinuria trials by city

Metilcrotonilglicinuria in Toronto Metilcrotonilglicinuria in Vancouver Metilcrotonilglicinuria in Montreal Metilcrotonilglicinuria in Calgary Metilcrotonilglicinuria in Edmonton Metilcrotonilglicinuria in Ottawa Metilcrotonilglicinuria in Winnipeg Metilcrotonilglicinuria in Quebec City Metilcrotonilglicinuria in Hamilton Metilcrotonilglicinuria in Kitchener Metilcrotonilglicinuria in London Metilcrotonilglicinuria in Halifax Metilcrotonilglicinuria in New York Metilcrotonilglicinuria in Los Angeles Metilcrotonilglicinuria in Chicago Metilcrotonilglicinuria in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease